Stock CHG CHULARAT HOSPITAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials Chularat Hospital

Equities

CHG

TH4539010Z03

Healthcare Facilities & Services

End-of-day quote Thailand S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
2.94 THB +1.38% Intraday chart for Chularat Hospital +0.68% -6.37%
May. 14 Chularat Hospital Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 Chularat Hospital Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 28,380 27,060 40,260 40,480 34,540 32,340 - -
Enterprise Value (EV) 1 29,398 27,626 37,915 39,278 33,823 31,040 30,759 29,869
P/E ratio 40.3 x 30.8 x 9.63 x 14.5 x 33.1 x 25.9 x 23.3 x 21.9 x
Yield 1.94% 2.03% 5.46% 4.35% 2.23% 2.5% 3.02% 3.31%
Capitalization / Revenue 5.49 x 4.98 x 3.43 x 4.01 x 4.47 x 3.73 x 3.43 x 3.2 x
EV / Revenue 5.69 x 5.09 x 3.23 x 3.89 x 4.38 x 3.58 x 3.26 x 2.95 x
EV / EBITDA 24.6 x 18.6 x 7.04 x 10.8 x 22 x 15.5 x 13.7 x 12.2 x
EV / FCF 111 x 27.4 x 10.7 x 21.3 x 35.3 x 24 x 22.7 x 19.5 x
FCF Yield 0.9% 3.65% 9.34% 4.69% 2.84% 4.17% 4.4% 5.13%
Price to Book 7.67 x 6.72 x 5.32 x 5.38 x 4.59 x 4.11 x 3.81 x 3.5 x
Nbr of stocks (in thousands) 11,000,000 11,000,000 11,000,000 11,000,000 11,000,000 11,000,000 - -
Reference price 2 2.580 2.460 3.660 3.680 3.140 2.940 2.940 2.940
Announcement Date 2/28/20 2/25/21 2/25/22 2/23/23 2/23/24 - - -
1THB in Million2THB
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,166 5,433 11,742 10,103 7,730 8,669 9,438 10,122
EBITDA 1 1,194 1,486 5,389 3,642 1,537 1,997 2,244 2,453
EBIT 1 863.9 1,133 5,038 3,260 1,097 1,338 1,559 1,719
Operating Margin 16.72% 20.85% 42.91% 32.27% 14.19% 15.43% 16.52% 16.98%
Earnings before Tax (EBT) 1 848.7 1,071 5,276 3,554 1,346 1,572 1,772 1,988
Net income 1 705.2 876.6 4,204 2,778 1,046 1,237 1,415 1,573
Net margin 13.65% 16.14% 35.8% 27.5% 13.53% 14.27% 14.99% 15.54%
EPS 2 0.0640 0.0800 0.3800 0.2530 0.0950 0.1134 0.1264 0.1340
Free Cash Flow 1 263.7 1,008 3,543 1,843 959.3 1,294 1,354 1,532
FCF margin 5.1% 18.56% 30.17% 18.25% 12.41% 14.93% 14.34% 15.13%
FCF Conversion (EBITDA) 22.09% 67.85% 65.74% 50.61% 62.39% 64.78% 60.33% 62.44%
FCF Conversion (Net income) 37.39% 115.04% 84.27% 66.34% 91.71% 104.64% 95.66% 97.37%
Dividend per Share 2 0.0500 0.0500 0.2000 0.1600 0.0700 0.0736 0.0888 0.0972
Announcement Date 2/28/20 2/25/21 2/25/22 2/23/23 2/23/24 - - -
1THB in Million2THB
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 2,473 - 3,486 3,866 3,571 2,784 6,356 2,026 1,721 1,716 1,799 2,093 2,123 2,021
EBITDA 1 - - 1,213 2,317 1,824 1,227 - 468 331.2 338.5 300.3 554.3 421.2 384.8
EBIT - - - 2,226 1,665 1,064 - 367.2 237.8 239.6 196.2 437.6 300.4 -
Operating Margin - - - 57.57% 46.61% 38.23% - 18.12% 13.82% 13.96% 10.91% 20.91% 14.15% -
Earnings before Tax (EBT) - - 1,031 2,290 1,729 1,133 2,861 363.5 328.5 305.5 261.9 426.8 352.2 -
Net income 1 - - 827.9 1,813 1,356 878.2 2,235 258.5 285.3 240.4 206 325.8 273.8 261.3
Net margin - - 23.75% 46.89% 37.98% 31.54% 35.16% 12.76% 16.58% 14.01% 11.46% 15.57% 12.9% 12.93%
EPS 2 - - 0.0753 0.1626 0.1233 0.0798 0.2031 0.0235 0.0264 0.0219 0.0187 0.0296 0.0200 0.0240
Dividend per Share 0.0200 0.0300 - - - - - - 0.0750 - - - - -
Announcement Date 8/14/20 2/25/21 8/11/21 2/25/22 5/13/22 8/15/22 8/15/22 11/11/22 2/23/23 5/11/23 8/10/23 11/14/23 2/23/24 5/14/24
1THB in Million2THB
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,018 566 - - - - - -
Net Cash position 1 - - 2,345 1,202 717 1,300 1,581 2,471
Leverage (Debt/EBITDA) 0.8527 x 0.3808 x - - - - - -
Free Cash Flow 1 264 1,008 3,543 1,843 959 1,294 1,354 1,532
ROE (net income / shareholders' equity) 19.4% 22.7% 72.5% 36.8% 13.9% 16% 17.2% 18%
ROA (Net income/ Total Assets) 11.8% 14.1% 50.2% 26.7% 10.2% 12.5% 13.2% 14.4%
Assets 1 5,987 6,233 8,375 10,415 10,272 9,867 10,704 10,898
Book Value Per Share 2 0.3400 0.3700 0.6900 0.6800 0.6800 0.7200 0.7700 0.8400
Cash Flow per Share 2 0.0900 0.1200 0.3600 0.2400 0.1900 0.1600 0.1900 0.2000
Capex 1 710 289 481 786 1,128 517 462 450
Capex / Sales 13.75% 5.32% 4.09% 7.78% 14.59% 5.96% 4.89% 4.44%
Announcement Date 2/28/20 2/25/21 2/25/22 2/23/23 2/23/24 - - -
1THB in Million2THB
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Chularat Hospital

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
2.94 THB
Average target price
3.368 THB
Spread / Average Target
+14.56%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CHULARAT HOSPITAL Stock Chularat Hospital
-6.37% 878M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 88.99B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+0.49% 25.03B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.88B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.43B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.77B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.21B
NATERA, INC. Stock Natera, Inc.
+70.11% 13.08B
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CHG Stock
  4. Financials Chularat Hospital